MSH2 and colorectal carcinoma: In Amsterdam-criteria negative LS CRC, these pooled mutation frequencies were 16.70% (95% CI: 14.53–19.13%) and 11.13% (95% CI: 9.49–13.42%) for hMLH1 and hMSH2 genes, respectively.